长沙招聘

Provide oversight of a study to ensure progress according to study timelines.
CTOM(Trial Management Track) is the leader of clinical trial team (CTT) (including representatives from CSUs/affiliates/CROs, GPE, Medical Operation, Biostatistics, Clinical Supplies Platform, Regulatory, Pharmacokinetics and other relevant departments) and responsible for the operational aspects of the study.
Liaise with the feasibility manager to review and assess country feasibility.
Liaise with clinical purchasing to prepare the RFP (request for proposal), review vendors’ specifications and oversee vendor activities and deliverables (i.e., Central Lab, IVRS, data management, monitoring Meeting Planner).
Liaise with coding and TIM representatives when applicable.
Develop and manage the study budget
Develop study budget in collaboration with clinical purchasing department, local CSU (clinical study unit), UMO (Unit management office), review and validate country study budget.
During study conduct, review and track budget spending and perform monitoring on study budget and make complementary budget if needed.
Select, set up and manage vendors
Define needs, tasks and responsibilities of external vendors, review contracts, estimate costs of logistical aspects of the study and ensure tracking payments for operational aspects of the study are done in collaboration with the Clinical Purchasing department.
Closely work with vendors to set up central services on time and in high quality in conjunction with the CTT and provide oversight during study conduct to ensure study needs fullfiled.
Ensure proper study documentation
Develop following study documents as the author: Monitoring Plan, Study Communication Plan, study-specific procedures and study operational material (e.g. study newsletters, memo, etc) as needed
Co-develop documents with vendors (specifications of central services, scope of work, operational manual, etc) in conjunction with the CTT.
Review CTT-developed documents including ES, protocol, amendments, and WSI (operational sections) , Data Management Plan, the Data Validation Plan, the Case Report Forms (including testing) and completion guidelines, data transfer plan, the Data Review & Surveillance Plan, recruitment and retention plan, committee chaters and/or other operational documents as requested to provide operational input (including on-time and high quality).
Ensure that clinical standards are followed for the study.
Ensure study documentation is properly maintained and archived in the Trial Master File (TMF) and relevant E-rooms and databases as required.
Ensure proper collection and validation of data and documentation on a timely manner
Assure proper overview and communicate to teams of monitoring activities, data flow, data validation and when applicable, coordinates the centralized review of procedures in collaboration with data manager, local CSU and relevant functions
Investigational Product (IP) Management.
Collaborate with the CSOM (Clinical Supply Operational Manager) to validate study IP needs, specifications, packaging, shipment (including resupply) and reconciliation process.
Collect, synthesize and report study information
职位要求：
Maintain and provide information for monthly study highlights (including enrollment curves and timelines) on a timely manner
Preparation and oversight of study audits/inspections both internal and external
Ensure preparation and proper responses to audit/inspection reports & consolidation of findings and communicate important observations to CTT and/or DPE and Team Leader.
Develop and implement immediate action plan at global CSU/sites level if needed.
Provide oversight and preparation for pre-approval inspections (PAI)
Upon request, prepare and assist in PAI preparation plan with the PAI project team.
Utilize designated tools developed to oversee quality (e.g. Polaris BO reports, etc) for an Inspection-readiness approach and to prepare for CSU CTTs & DRS meetings to optimize monitoring efficiency & quality

赛诺菲集团
赛诺菲集团是一家全球领先的多元化医药健康企业，专注于患者需求，传播健康。
 全球100,000余名员工，业务遍及100个国家
 新兴市场实力均衡，表现强劲，位列***
 多元领域，覆盖处方药、健康药业产品、疫苗和动物保健品
 疫苗领域的领导者
 领先动物保健市场
 2011年集团净销售额达334亿欧元

赛诺菲在中国
赛诺菲是首批在中国开设办事处的跨国制药集团，也是国内增长最快的医药健康企业之一。目前，赛诺菲在中国200多个城市拥有6000余名员工。
   
传承悠久历史、持续开拓进取
赛诺菲一直以来秉承对中国的承诺。1982年，赛诺菲成为首批在中国开设办事处的跨国制药企业之一。今天，赛诺菲已跻身中国医药健康市场的领军企业。赛诺菲的中国总部位于上海，并在北京、天津、沈阳、济南、上海、杭州、南京、武汉、成都、广州和乌鲁木齐共设11家区域办公室。

独特的医药健康产品系列、满足中国公共卫生需求
从预防到治疗，赛诺菲全方位满足中国的公共健康需求。集团的疫苗事业部赛诺菲巴斯德是中国领先的疫苗企业。赛诺菲在心血管/血栓、糖尿病、肿瘤、内科和中枢神经系统等关键的治疗领域拥有领先产品。2010年，杭州赛诺菲民生健康药业有限公司的成立标志着赛诺菲进入中国的非处方药市场。2011年2月，赛诺菲完成了对BMP太阳石的收购。

大幅投资工业建设、满足中国市场需求
赛诺菲目前在中国拥有六家生产基地，包括北京制药工厂、杭州制药工厂、杭州赛诺菲民生健康药业工厂、南昌梅里亚动物保健工厂、深圳赛诺菲巴斯德疫苗工厂、以及唐山健康药业工厂。

完善的研发架构、双赢的研发合作模式
在中国，赛诺菲具有从药物靶点发现到后期临床研究的整体研发实力。集团在上海设有中国研发中心和亚太研发中心，并在北京和成都分别设有研发机构。自2008年以来，赛诺菲与中国权威科研机构开展了10多项战略合作，在癌症、干细胞、糖尿病和老年疾病等前沿研究领域探索创新药物

依托于强劲的研发能力和多领域领先水平的广泛的医药产品资源，公司在中国的市场份额不断攀升，公司规模不断扩大，飞速发展的业务给了我们与更多优秀人才合作的机会。

如需了解更多信息，请访问*************


现在就行动！把握机遇，加入我们，您的职业生涯将与赛诺菲共同成长！抓住机会，来亲身体验我们所秉持的胆略、创新、团结、勇气的价值观。

请将您的中英文简历发给我们，并在email标题栏注明您所申请的职位名称。每个职位申请一次即可，请不要重复投递简历。谢谢！